0001689813-19-000118.txt : 20191218
0001689813-19-000118.hdr.sgml : 20191218
20191218213931
ACCESSION NUMBER: 0001689813-19-000118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191216
FILED AS OF DATE: 20191218
DATE AS OF CHANGE: 20191218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AGUIAR ERIC
CENTRAL INDEX KEY: 0001262325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 191294012
MAIL ADDRESS:
STREET 1: 888 7TH AVENUE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
wf-form4_157672315313106.xml
FORM 4
X0306
4
2019-12-16
0
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001262325
AGUIAR ERIC
C/O AISLING CAPITAL LLC
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
1
0
0
0
Common Shares
2019-12-16
4
M
0
3537
20.79
A
3537
I
By Spouse
Common Shares
2019-12-16
4
S
0
3537
55.1271
D
0
I
By Spouse
Employee Stock Option (Right to Buy)
20.79
2019-12-16
4
M
0
3537
0
D
2027-12-06
Common Shares
3537.0
15218
I
By Spouse
These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 - $55.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The option, representing a right to purchase a total of 30,436 shares was granted on December 7, 2017, vesting in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date. The optionholder previously exercised the option with respect to 7,609 shares on February 4, 2019 and 4,072 shares on December 9, 2019.
This employee stock option is held by the Reporting Person's spouse.
/s/ Jim Engelhart, Attorney-in-fact
2019-12-18